PCaVision Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $2.1M

  • Investors
  • 9

PCaVision General Information

Description

Developer of an ultrasound imaging medical device designed to detect, localize, and characterize prostate cancer tumors with improved efficiency. The company's device replaces the biopsy-based diagnosis by eliminating infection risk, reducing cost, and increasing patient comfort and outcomes, enabling clinicians to treat and predict prostate cancer without any hassle.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • JADS Venture Campus
  • Sint Janssingel 88
  • 5211 DA S-Hertogenbosch
  • Netherlands
+31 073
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • JADS Venture Campus
  • Sint Janssingel 88
  • 5211 DA S-Hertogenbosch
  • Netherlands
+31 073

PCaVision Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PCaVision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Equity Crowdfunding 01-Nov-2025 $2.1M Completed Generating Revenue
13. Later Stage VC (Series A) 16-Sep-2025 Completed Generating Revenue
12. Later Stage VC 01-Jan-2021 Completed Generating Revenue
11. Later Stage VC Completed Generating Revenue
10. Grant 01-Dec-2020 Completed Generating Revenue
9. Seed Round 17-Feb-2020 Completed Generating Revenue
8. Grant 01-Dec-2019 Completed Startup
7. Grant 01-Dec-2018 Completed Startup
6. Seed Round 10-Jul-2018 Completed Startup
5. Grant 01-Dec-2017 $1.19M Completed Startup
To view PCaVision’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PCaVision Patents

PCaVision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3347874-A1 Imaging of dispersion and velocity of contrast agents Active 09-Sep-2015
EP-3347874-B1 Imaging of dispersion and velocity of contrast agents Active 09-Sep-2015
US-10789711-B2 Imaging of dispersion and velocity of contrast agents Active 09-Sep-2015
US-20200234446-A1 Imaging of dispersion and velocity of contrast agents Active 09-Sep-2015
US-9141766-B2 Perfusion scanning detects angiogenesis from similarity in evolution of local concentrations of contrast agent Active 27-Sep-2011
To view PCaVision’s complete patent history, request access »

PCaVision Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PCaVision Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Living Hope VC Venture Capital Minority
CbusineZ Corporate Venture Capital Minority
National Institutes of Health Government
Hanarth Fonds Other
NLC Health Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

PCaVision FAQs

  • When was PCaVision founded?

    PCaVision was founded in 2008.

  • Where is PCaVision headquartered?

    PCaVision is headquartered in S-Hertogenbosch, Netherlands.

  • What is the size of PCaVision?

    PCaVision has 31 total employees.

  • What industry is PCaVision in?

    PCaVision’s primary industry is Diagnostic Equipment.

  • Is PCaVision a private or public company?

    PCaVision is a Private company.

  • What is PCaVision’s current revenue?

    The current revenue for PCaVision is .

  • How much funding has PCaVision raised over time?

    PCaVision has raised $5.12M.

  • Who are PCaVision’s investors?

    Living Hope VC, CbusineZ, National Institutes of Health, Hanarth Fonds, and NLC Health Ventures are 5 of 9 investors who have invested in PCaVision.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process